Eugene Myron Holuka Citius Pharmaceuticals, Inc. (CTXR) insider trading activity

Eugene Myron Holuka is Director of Citius Pharmaceuticals, Inc.. Currently has a direct ownership of 2,367 shares of CTXR, which is worth approximately $1,230. The most recent transaction as insider was on Mar 13, 2024, when has been sold 48 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $36. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.37K

0% 3M change

n/a 12M change

Total Value Held $1,230

Eugene Myron Holuka Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Mar 13 2024	SELL Payment of exercise price or tax liability	$36 $0.75 p/Share	48 Reduced 1.99%	2,367 Common Stock
Mar 13 2024	BUY Exercise of conversion of derivative security	$48 $0.02 p/Share	2,415 Added 50.0%	2,415 Common Stock

Also insider at

TENK

TenX Keane Acquisition

Director

EMH